Professional Documents
Culture Documents
RESPONSE TO ALTERED VENTILATORY FUNCTION Irene Edi
RESPONSE TO ALTERED VENTILATORY FUNCTION Irene Edi
Etiology
The following are major risk factors for DVT leading to Pulmonary Embolism
1. Prolonged immobilization
Pulmonary Circulation 2. Central Venous catheters
3. Surgery (Orthopedic surgery)
4. Obesity
5. Advancing age
6. Hypercoagulability
7. History of thromboembolism
8. Cancer diagnosis
Virchow’s Triad
Virchow’s Triad gives us three main factors that can lead to blood clot
formation within a vein.
Remember: “SHE”
Stasis of Venous Circulation
• Blood cannot just hang out and become static within a vessel
(Immobilization, varicose veins, traveling for long hours w/o
moving extremities, pregnancy/obesity)
Hypercoagulability
• Increase or high coagulation process in the body
Pathophysiology (Cancer, Severe illness (sepsis), Dehydration, Usage of
Estrogen (birth control), Heparin Induced Thrombocytopenia
Large emboli obstruct pulmonary blood flow (HIT), Postpartum Period)
Decreased systemic oxygenation
Endothelial damage to the vein
• This endothelial is a layer of cells that lines the inside of the vein.
Pulmonary tissue hypoxia
• This damage stimulates platelets and the coagulation process
Potential death What are some conditions that cause damage the endothelial lining?
IV drug usage (venipuncture)
Indwelling devices (central line catheter, IV line, or heart valves
etc.)
Medications that are damaging to the vein
Trauma or injury to the vessel (surgery)
Nursing Interventions
Radiographic Assessment
• Chest X-ray may show evidence of PE, if its is large Nonsurgical Management
• Lung infiltration may be present around the embolism site
• Spiral CT Scan are often used to diagnose PE 1. Oxygen Therapy
• Transesophageal echocardiography 2. Monitoring
• Doppler ultrasound 3. Anticoagulant Therapy
• Impedance plethysmography (IPG) is used to document PE
and DVT Surgical Management
Transesophageal echocardiography
Nasal Cannula
Delivers 2-5 L/min
21-50% FiO2
Venturi Mask
Mechanical Ventilation
Assess the client continually for any changes in status Embolectomy — also sometimes called thrombectomy — is the
removal of a blood clot (thrombus) that's keeping blood from flowing
Check every 1 to 2 hours: through a blood vessel normally.
• Monitor aPTT (activated partial thromboplastin time): 1.5 to Preventions (Health Teachings)
2.5 times normal ranges
Application and regular usage of pneumatic compression devices like
– >80 seconds risk for bleeding - dose decreased (SCDs) Sequential Compression Device per MD order. These devices
– <60 seconds NOT therapeutic - risk for clots and may wrap around the legs and inflate and deflate to help move blood flow
need dosage increased (similar to walking).
– Used in combination with Warfarin until INR is
therapeutic and then Heparin is discontinued. • They must fit properly.
• They’re NOT to be applied to the extremity that has an active DVT
Antidote: protamine sulfate (can lead to dislodgement).
• Make sure the patient is wearing them while sitting or in bed.
Take them off when the patient is walking. Make sure they’re
plugged in, actually inflating and deflating (ask the patient).
2. Warfarin: Vitamin K antagonist • Also, make sure they are changed and cleaned regularly.
• Since it’s a Vitamin K antagonist, it will work to inhibit
Patient needs to be ambulating daily and out of the bed with all meals,
clotting factors from using Vitamin K.
if possible.
• Slow onset - takes 3-5 day for patient to become
therapeutic
Teach patient to perform exercises by flexing and extending feet and
• Taken orally
legs every hour while awake.
• Monitor PT/INR (Prothrombin time/International
Normalized Ratio Compression stockings per MD order: provides a specific amount of
• therapeutic INR is 2-3 (less than 2 is not therapeutic)
compression to help decrease risk of blood clot development.
and greater than 3 at risk for bleeding)
Prophylactic medications: after surgery (post-op), especially joint
Antidote: vitamin K
replacement surgery like the hip… Example: Enoxaparin (subq injection)